Cheers. That's a far more eloquent way of the point I was originally trying to make in regards to patient choice vs doctor recommendations (they should definitely agree). And that in light of this, if more patients knew about Cardiocel, no reasonable cardiac surgeon would suggest an inferior product hence a more rapid uptake.
Sorry it wasn't clearer, crazy morning here. Though not as crazy as the sp action - if I had half a mill to sell, wouldn't let them go for less than 20cps off the back of 2 fantastic recent announcements!
world congress of cardiology 2014 melbourne , page-14
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.75 | $48.08K | 2.689K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.91 | 32 | 2 |
View Market Depth
| Last trade - 14.38pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |